Literature DB >> 7658781

Linkage to BRCA2 region in hereditary male breast cancer.

S Thorlacius1, L Tryggvadottir, G H Olafsdottir, J G Jonasson, H M Ogmundsdottir, H Tulinius, J E Eyfjord.   

Abstract

Breast cancer is rare in men, and family history of the disease is a risk factor. The recently discovered BRCA2 gene on chromosome 13q is thought to account for some families with increased risk of breast cancer, including male breast cancer. We describe a family with multiple cases of male breast cancer but, interestingly, no increase in female breast cancer. Linkage to the BRCA2 region is demonstrated and all the affected men share the same haplotype for the BCRA2 markers and loss of the other alleles in their tumours.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658781     DOI: 10.1016/s0140-6736(95)91383-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  An updated review of epidemiology, risk factors, and management of male breast cancer.

Authors:  Noman Ahmed Jang Khan; Maria Tirona
Journal:  Med Oncol       Date:  2021-03-15       Impact factor: 3.064

2.  Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.

Authors:  J V Rajan; M Wang; S T Marquis; L A Chodosh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 3.  [Oncology '96].

Authors:  F Hartmann; M Pfreundschuh
Journal:  Med Klin (Munich)       Date:  1997-02-15

4.  Study of a single BRCA2 mutation with high carrier frequency in a small population.

Authors:  S Thorlacius; S Sigurdsson; H Bjarnadottir; G Olafsdottir; J G Jonasson; L Tryggvadottir; H Tulinius; J E Eyfjörd
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

Authors:  Inmaculada de Juan; Sarai Palanca; Asunción Domenech; Lidia Feliubadaló; Ángel Segura; Ana Osorio; Isabel Chirivella; Miguel de la Hoya; Ana Beatriz Sánchez; Mar Infante; Isabel Tena; Orland Díez; Zaida Garcia-Casado; Ana Vega; Àlex Teulé; Alicia Barroso; Pedro Pérez; Mercedes Durán; Estela Carrasco; M José Juan-Fita; Rosa Murria; Marta Llop; Eva Barragan; Ángel Izquierdo; Javier Benítez; Trinidad Caldés; Dolores Salas; Pascual Bolufer
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

6.  Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.

Authors:  Liesel M Fitzgerald; Shannon K McDonnell; Erin E Carlson; Wendy Langeberg; Laura M McIntosh; Kerry Deutsch; Elaine A Ostrander; Daniel J Schaid; Janet L Stanford
Journal:  Eur J Hum Genet       Date:  2010-04-21       Impact factor: 4.246

7.  Multidisciplinary meeting on male breast cancer: summary and research recommendations.

Authors:  Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie Gralow; Gabriel Hortobagyi; Fatima Cardoso
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

8.  The effect of a single BRCA2 mutation on cancer in Iceland.

Authors:  H Tulinius; G H Olafsdottir; H Sigvaldason; A Arason; R B Barkardottir; V Egilsson; H M Ogmundsdottir; L Tryggvadottir; S Gudlaugsdottir; J E Eyfjord
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

9.  Treatment outcomes for male breast cancer: a single-centre retrospective case-control study.

Authors:  M Rushton; A Kwong; H Visram; N Graham; W Petrcich; S Dent
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

10.  Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

Authors:  Yu Chuan Tai; Susan Domchek; Giovanni Parmigiani; Sining Chen
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.